Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

Clinical trial NCT04980638 · RECRUITING

Trial details

NCT number: NCT04980638
Sponsor: EspeRare Foundation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

Start date: 2022-04-26
Primary completion: 2027-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.